Alyotech

Company developing vaccine and small molecules to treat and PREvent viral diseases and cancers

Total raised

€20M

€20,236,363

Funding rounds

Investors

distinct backers

Active since

2007-05

latest 2010-06

Funding by year

EUR raised per year

High confidence

Raise-next likelihood15

base rate 42% for Early VC

Exit likelihood16

base rate 12% (2+ rounds)

Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

3 rounds

Date	Stage	Amount	Investors
2010-07-01	Early VC	€4.0M	Iris Capital	View deal →
2008-07-01	Early VC	€4.0M	Iris Capital	View deal →
2007-06-01	Growth/Late	€12M	Iris Capital	View deal →

same sector or country